JESSICA MARTIN: Open Payments
NPI 1871858035 · ALEXANDER CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 18 payments from 10 companies in 2025. Trend: 2023 $534 · 2024 $407 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| ABBVIE INC. | 2 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Molnlycke Health Care US, LLC | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $14 |
Products named: TRINTELLIX, BREZTRI, MOUNJARO, UBRELVY, Mepilex Border Post-Op Ag, INSPIRE, INGREZZA, QULIPTA.
Industry payments across AL — which companies pay providers there.
